334
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Association between ulcer site and outcome in complicated peptic ulcer disease: a Danish nationwide cohort study

, &
Pages 1165-1171 | Received 25 Feb 2016, Accepted 03 May 2016, Published online: 01 Jun 2016

References

  • Barkun A, Leontiadis G. Systematic review of the symptom burden, quality of life impairment and costs associated with peptic ulcer disease. Am J Med. 2010;123:358–366.
  • Stewart B, Khanduri P, McCord C, et al. Global disease burden of conditions requiring emergency surgery. Br J Surg. 2014;101:e9–22.
  • Søreide K, Thorsen K, Harrison EM, et al. Perforated peptic ulcer. Lancet. 2015;386:1288–1298.
  • Lau JY, Sung J, Hill C, et al. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion. 2011;84:102–113.
  • Elmunzer BJ, Young SD, Inadomi JM, et al. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol. 2008;103:2625–2632.
  • García-Iglesias P, Villoria A, Suarez D, et al. Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer. Aliment Pharmacol Ther. 2011;34:888–900.
  • Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316–321.
  • Sung JJY, Tsoi KKF, Ma TKW, et al. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol. 2010;105:84–89.
  • Boey J, Choi SK, Poon A, et al. Risk stratification in perforated duodenal ulcers. A prospective validation of predictive factors. Ann Surg. 1987;205:22–26.
  • Møller MH, Engebjerg MC, Adamsen S, et al. The Peptic Ulcer Perforation (PULP) score: a predictor of mortality following peptic ulcer perforation. A cohort study. Acta Anaesthesiol Scand. 2012;56:655–662.
  • Thorsen K, Søreide JA, Søreide K. What is the best predictor of mortality in perforated peptic ulcer disease? A population-based, multivariable regression analysis including three clinical scoring systems. J Gastrointest Surg. 2014;18:1261–1268.
  • Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974;2:394–397.
  • Kim BJ, Park MK, Kim S-J, et al. Comparison of scoring systems for the prediction of outcomes in patients with nonvariceal upper gastrointestinal bleeding: a prospective study. Dig Dis Sci. 2009;54:2523–2529.
  • Møller MH, Adamsen S, Thomsen RW, et al. Multicentre trial of a perioperative protocol to reduce mortality in patients with peptic ulcer perforation. Br J Surg. 2011;98:802–810.
  • De Groot NL, Van Oijen MGH, Kessels K, et al. Reassessment of the predictive value of the Forrest classification for peptic ulcer rebleeding and mortality: can classification be simplified? Endoscopy. 2014;46:46–52.
  • Laursen SB, Hansen JM, Schaffalitzky de Muckadell OB. The Glasgow Blatchford score is the most accurate assessment of patients with upper gastrointestinal hemorrhage. Clin Gastroenterol Hepatol. 2012;10:1130–1135.e1.
  • Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356:1318–1321.
  • Lu Y, Loffroy R, Lau JYW, et al. Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding. Br J Surg. 2014;101:e34–e50.
  • Quan S, Frolkis A, Milne K, et al. Upper-gastrointestinal bleeding secondary to peptic ulcer disease: incidence and outcomes. World J Gastroenterol. 2014;20:17568–17577.
  • Kocer B, Surmeli S, Solak C, et al. Factors affecting mortality and morbidity in patients with peptic ulcer perforation. J Gastroenterol Hepatol. 2007;22:565–570.
  • Noguiera C, Silva AS, Nunes Santos J, et al. Perforated peptic ulcer: main factors of morbidity and mortality. World J Surg. 2003;27:782–787.
  • Testini M, Portincasa P, Piccinni G, et al. Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer. World J Gastroenterol. 2003;9:2338–2340.
  • Chou NH, Mok KT, Chang HT, et al. Risk factors of mortality in perforated peptic ulcer. Eur J Surg. 2000;166:149–153.
  • von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–349.
  • Laursen SB, Jørgensen HS, Schaffalitzky de Muckadell OB. National consensus on management of peptic ulcer bleeding in Denmark 2014. Dan Med J. 2014;61:B4969.
  • Mainz J, Krog BR, Bjørnshave B, et al. Nationwide continuous quality improvement using clinical indicators: the Danish National Indicator Project. Int J Qual Health Care. 2004;16:i45–i50.
  • Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39:22–25.
  • Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39:30–33.
  • Moller MH, Larsson HJ, Rosenstock S, et al. Quality-of-care initiative in patients treated surgically for perforated peptic ulcer. Br J Surg. 2013;100:543–552.
  • Rosenstock SJ, Møller MH, Larsson H, et al. Improving quality of care in peptic ulcer bleeding: nationwide cohort study of 13,498 consecutive patients in the Danish clinical register of emergency surgery. Am J Gastroenterol. 2013;108:1449–1457.
  • Kirkwood B, Sterne J. Essential medical statistics. 2nd ed. Blackwell Scientific; 2003.
  • Vesin A, Azoulay E, Ruckly S, et al. Reporting and handling missing values in clinical studies in intensive care units. Intensive Care Med. 2013;39:1396–1404.
  • Marshall A, Altman DG, Holder RL, et al. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol. 2009;9:57.
  • Broll S, Glaser S, Kreienbrock L. Calculating sample size bounds for logistic regression. Prev Vet Med. 2002;54:105–111.
  • Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998;17:1623–1634.
  • Sankar a, Johnson SR, Beattie WS, et al. Reliability of the American Society of Anesthesiologists physical status scale in clinical practice. Br J Anaesth. 2014;113:424–432.
  • Bour B, Person B, Calès P, et al. Interobserver agreement on endoscopic diagnosis of bleeding peptic ulcers. Gastrointest Endosc. 1997;46:27–32.
  • Leontiadis GI, Molloy-Bland M, Moayyedi P, et al. Effect of comorbidity on mortality in patients with peptic ulcer bleeding: systematic review and meta-analysis. Am J Gastroenterol. 2012;108:331–345.
  • Nahon S, Pariente A. Impact of comorbidity on mortality in patients with peptic ulcer bleeding: confirmative data of a French prospective study. Am J Gastroenterol. 2013;108:1532–1533.
  • Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014;19:1–5.
  • Groenen MJM, Kuipers EJ, Hansen BE, et al. Incidence of duodenal ulcers and gastric ulcers in a Western population: back to where it started. Can J Gastroenterol. 2009;23:604–608.
  • Musumba C, Jorgensen A, Sutton L, et al. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Aliment Pharmacol Ther. 2012;36:48–56.
  • Yeomans ND. The ulcer sleuths: the search for the cause of peptic ulcers. J Gastroenterol Hepatol. 2011;26:35–41.
  • Møller MH, Adamsen S, Thomsen RW, et al. Preoperative prognostic factors for mortality in peptic ulcer perforation: a systematic review. Scand J Gastroenterol. 2010;45:785–805.
  • Bytzer P, Teglbjaerg PS. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis–results from a randomized trial with 2-year follow-up. Am J Gastroenterol. 2001;96:1409–1416.
  • Gisbert JP, Calvet X. Review article: Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Ther. 2009;30:791–815.
  • Charpignon C, Lesgourgues B, Pariente a, et al. Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake. Aliment Pharmacol Ther. 2013;38:946–954.
  • Wong GLH, Wong VWS, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;137:525–531.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.